Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy

Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy

Data on the use of Granulocyte colony-stimulating factor (G-CSF) in pregnant cancer patients are scarce. The International Network of Cancer, Infertility and Pregnancy (INCIP) reviewed data of pregnant patients treated with chemotherapy and G-CSF, and their offspring. Among 2083 registered patients,...

Full description

Bibliographic Details
Main Authors: Claudia Berends, Charlotte Maggen, Christianne A. R. Lok, Mathilde van Gerwen, Ingrid A. Boere, Vera E. R. A. Wolters, Kristel Van Calsteren, Heidi Segers, Marry M. van den Heuvel-Eibrink, Rebecca C. Painter, Mina Mhallem Gziri, Frédéric Amant
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
pregnancy
cancer treatment
G-CSF
maternal outcome
neonatal outcome
Online Access:https://www.mdpi.com/2072-6694/13/6/1214

Internet

https://www.mdpi.com/2072-6694/13/6/1214

Similar Items